Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,799 total articles
Candel Therapeutics, a clinical-stage biopharmaceutical company specializing in multimodal immunotherapies for cancer, announced that its CEO will participate in several prominent investor conferences in September 2026. The company highlighted its two clinical-stage immunotherapy platforms and ongoing clinical trials, along with regulatory designat…
Sysco Corporation announced it will webcast its presentation at the Barclays 19th Annual Global Consumer Conference on September 9, 2026. The webcast will provide investors with insights into the company’s performance and operations. Sysco is a global leader in food distribution, serving various sectors including restaurants, healthcare, educationa…
InnovAge Holding Corp., a provider of comprehensive healthcare programs for frail and dual-eligible seniors via the PACE model, announced it will release its fiscal 2026 Q4 and full-year financial results on September 8, 2026, followed by a conference call. The company will also present at the Wells Fargo 21st Annual Healthcare Conference on Septem…
Cerence Inc. announced the repurchase of $10 million of its 1.50% Convertible Senior Notes due 2028 at 92.75% of principal plus accrued interest, aiming to lower interest expenses, reduce dilution risk, and improve leverage, reflecting strong cash flow and strategic financial management.
SkinHealth Systems announced the launch of Hydrafacial Impact, a provider education initiative aimed at helping aesthetic practices maximize their Hydrafacial investments and drive sustainable growth through practical training and proven strategies.
XBP Global Holdings, a US-listed technology company, announced a contract with British Airways to deploy its flagship Plexus® AI solution. The AI platform will automate maintenance workflows, manage servicing histories, and replace legacy systems within British Airways' fleet operations, enhancing operational efficiency and compliance with data pri…
Micron Technology promotes Manish Bhatia to President & COO and Dr. Scott DeBoer to President & Chief Technology and Products Officer to strengthen execution and accelerate innovation amid growing demand for advanced memory solutions fueled by AI.
Currenc Group Inc., through its subsidiary CURRENC Capital, has entered a strategic partnership with Securitize Corp. to promote issuer-sponsored tokenization of public company shares. This collaboration leverages Currenc's experience as one of the first Nasdaq-listed companies to tokenize its shares and aims to modernize equity ownership and settl…
Greenland Mines Ltd, a Nasdaq-listed critical minerals developer, announced the pricing of a $20 million public offering of 4 million shares aimed at financing the acquisition of the Sarfartoq Nd-Pr Rare Earth Element Project and supporting general corporate purposes. The offering closing is expected around August 27, 2026. The company intends to u…
Rezolve Ai announced an Investor Day event on October 6, 2026, at Nasdaq MarketSite to showcase its agentic commerce business and expanding AI infrastructure capabilities. The company highlighted the commercial deployment of its distributed database technology by Google Cloud, validating its expansion into the AI data infrastructure market. Managem…
NewAmsterdam Pharma announced upcoming presentations at the European Society of Cardiology Congress highlighting data from its late-stage trials of obicetrapib, a novel oral CETP inhibitor designed to lower LDL cholesterol in patients at risk of cardiovascular disease. The company has completed enrollment in a large Phase 3 outcomes trial and partn…
CTS Corporation announced that its current sensing solutions are now available through a wider network of authorized distribution partners. This expansion aims to provide faster access, local support, and scalable supply for customers in diverse, fast-growing markets including data centers, industrial automation, medical devices, aerospace, and tel…
Eva Live Inc. announced a strategic white-label partnership with Domain Development Corporation to integrate EvaBrain, its proprietary AI platform, into DDC-operated digital properties. This collaboration aims to transform traditional web experiences into AI-driven conversational interfaces, enhancing user interaction and monetization potential acr…
Odyssey Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced that its management team will participate in several investor conferences in September 2026, including Cantor Global Healthcare, Morgan Stanley Global Healthcare, and H.C. Wainwright Global Investment Conferences. The company …
AXIL Brands, Inc., a U.S.-based consumer products company specializing in hearing protection and enhancement solutions, announced the launch of its next-generation wireless earbuds, the XCOR II, set for release on September 15, 2026. The new product features advanced noise reduction, enhanced soundstage, and improved battery life, with initial orde…
PowerCompute announced their GPU deployed at the Oklahoma facility achieved Verified status on Vast.ai's compute marketplace, indicating top machine reliability and performance. The company plans to add a second GPU soon and aims for Certified Datacenter status by meeting ISO/IEC 27001 certification and deploying at least five GPUs. This expansion …
Mineralys Therapeutics, a biopharmaceutical company developing treatments for hypertension and related diseases, announced its management will participate in the Wells Fargo 21st Annual Healthcare Conference with a fireside chat webcast on September 9, 2026.
High Roller Technologies, a publicly traded online gaming and prediction markets company, announced the completion and winners of its eight-week ROLR Free-To-Trade Prediction Challenge held from June 2 through August 12, 2026. Michael D. Franz was named Season Champion and awarded $75,000 after finishing first on the leaderboard. The competition se…
Cre8 Enterprise Limited, a financial printing service provider based in Hong Kong and listed on Nasdaq, announced record customer numbers and project backlog as of mid-2026, driven by increased regional capital market activity, notably a surge in IPO filings to the Hong Kong Stock Exchange. The company is optimistic about future demand and aims to …
Syntec Optics Holdings, Inc. (NASDAQ: OPTX), a leading manufacturer of high-precision optics and photonics, announced a new recurring order to build specialized waveguides for communication satellites. The company is scaling production to meet urgent demand from a top-tier customer, strengthening its position in the expanding space economy. Financi…
Rail Vision Ltd. achieved significant commercial momentum in the first half of 2026, with revenues surpassing $1 million, a 328% increase from the prior year period. Key achievements include integration of its ShuntingYard technology into Railserve’s YardGUARD system in the U.S., successful field testing with Israel Railways, and continued global b…
Abercrombie & Fitch Co. announced record net sales of $1.3 billion for Q2 fiscal 2026, marking the 15th consecutive quarter of growth with sales increases across all regions, led by an 8% rise in the Abercrombie brand. Operating margin reached 20%, and EPS was $4.17, outperforming prior outlook partly due to a $100 million IEEPA tariff refund benef…
BridgeBio Pharma has initiated dosing of the first participant in ASCEND-ATTR, a Phase 3b/4 clinical study designed to assess the long-term effects of acoramidis, an oral transthyretin stabilizer, on cardiac structure, function, and amyloid burden in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Building on prior Phase 3 ATTRibute-C…
Eikon Therapeutics, a late-stage clinical biopharmaceutical company focusing on oncology and innovative drug development, announced its participation in two key healthcare investor conferences in September 2026. The company's CEO and CFO will engage in fireside chats to discuss business strategies and recent progress. The company leverages propriet…
Trevi Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq (TRVI), announced acceptance of two abstracts for presentations at the ERS Congress 2026 in Barcelona. The presentations focus on quality-of-life outcomes from their Phase 2b CORAL and Phase 2a RIVER trials evaluating their investigational therapy, oral nalbuphine exten…
